 RICHMOND, Va.--BUSINESS WIRE--Aditxt, Inc. Aditxt Nasdaq: ADTX, a biotech innovation company with a mission to improve the health of the immune system, announced today the pricing of an underwritten public offering of 2,833,333 shares of its common stock at a public offering price of 1.50 per share, for gross proceeds of 4.25 million, before deducting underwriting discounts and offering expenses. Aditxt plans to use a portion of the net proceeds of approximately 3.91 million from thi 